Journal of Pharmacology and Pharmacotherapeutics

CASE REPORT
Year
: 2020  |  Volume : 11  |  Issue : 2  |  Page : 75--77

Ticagrelor-Induced complete heart block: A rare entity


Wagle Varun Anand1, Isha khadke1, R Padmakumar2, M Sudhakar Rao2, Bharti Chogtu1 
1 Department of Pharmacology Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
2 Department of Cardiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India

Correspondence Address:
Isha khadke
Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal - 576 104, Karnataka
India

Ticagrelor, a purinergic P2Y12 receptor blocker, is a potent platelet antagonist and an important component in the treatment for acute coronary syndromes identified to have a potential risk to cause bradyarrhythmias. Here, we report the case of a diabetic patient of unstable angina with left bundle branch block who was prescribed ticagrelor post angioplasty. Electrocardiogram (ECG) revealed a complete heart block after about 1 week. Ticagrelor was stopped and replaced by clopidogrel. The patient became asymptomatic and ECG showed baseline rhythm after 1 week of stoppage of ticagrelor.


How to cite this article:
Anand WV, khadke I, Padmakumar R, Rao M S, Chogtu B. Ticagrelor-Induced complete heart block: A rare entity.J Pharmacol Pharmacother 2020;11:75-77


How to cite this URL:
Anand WV, khadke I, Padmakumar R, Rao M S, Chogtu B. Ticagrelor-Induced complete heart block: A rare entity. J Pharmacol Pharmacother [serial online] 2020 [cited 2021 Jan 21 ];11:75-77
Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2020;volume=11;issue=2;spage=75;epage=77;aulast=Anand;type=0